Florian Witte Email

VP, Head Alliance Management and Early-Stage Project Leadership . Pieris Pharmaceuticals

Boston, MA

Location

w****@pieris.com

Primary Email

LinkedIn

Current Roles

Employees:
0
Revenue:
$17.4M
About
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS. Pieris is currently hiring in Boston and Freising, Germany. See here for our full list of job openings and information on applying: https://www.pieris.com/careers
Pieris Pharmaceuticals Address
225 Franklin St.
Boston, MA
United States
Pieris Pharmaceuticals Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.